Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer

摘要: Abstract Objectives We previously reported a 10% rate of catheter complications, including inflow obstruction and infection, using fenestrated to administer intraperitoneal (IP) chemotherapy for ovarian cancer. Because recent reports higher rates we performed this study update our experience with the catheter. Methods reviewed medical records all patients who had placed at institution from 5/97–5/06. Data were collected regarding patient demographics, surgical procedure, timing insertion, reasons discontinuing IP chemotherapy. Results identified 342 catheters whom follow-up data available. Nine (3%) required discontinuation due complications. Three experienced 5 obstruction, 1 patient's port could not be accessed. Seventy-one (21%) discontinued unrelated The percentage completed intended regimen was similar underwent bowel resection (22/30 [73%]) compared those (226/312 [72%]) ( P =1.0). Conclusions continues associated low risk catheter-related even in setting increase utilization during upfront chemotherapy, suggest that is still feasible method administration